- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
CORRELATION OF INTERLEUKIN-33 WITH SOME BIOCHEMICAL VARIABLES IN CHRONIC HEPATITIS B PATIENTS IN AL-FALLUJAH CITY | ||
| Anbar Science Journal | ||
| Volume 1, Issue 1, February 2025, Pages 22-30 PDF (625.91 K) | ||
| Document Type: Original Article | ||
| DOI: 10.63298/asj.2025.185249 | ||
| Authors | ||
| Hiba A. K. AL- Hadithe1; Shakir F.T. Alaaraji2* 2 | ||
| 1Department of Chemistry, College of Sciences, University Of Anbar, Ramadi, Iraq | ||
| 2Department of Chemistry, College of Education for Pure Sciences, University Of Anbar, Ramadi, Iraq | ||
| Abstract | ||
| Hepatitis B virus (HBV) disease is one of the main reasons of cirrhosis, chronic hepatitis, eventually hepatocellular carcinoma (HCC); as a result, it can be extremely harmful to the liver. Main goal of this paper to explore the correlation of interleukin (IL) 33with certain biochemical parameters in Iraqi patients’ with chronic hepatitis B (CHB). This research included 40 CHB patients from Al- Fallujah city and 40 healthy controls (HCs). The serum concentration of IL-33 was established using an enzyme linked immunosorbent assay (ELISA), while the ratio of waist to thoracic (W/T), waist to neck (W/N), waist to hip (W/H), systolic blood pressure (SBP), diastolic blood pressure (DBP), and rate of pulses (ROP) were carefully measured and documented. IL-33, was discovered to be increased in CHB patients in comparison to HCs (P<0.000l), BMI, W/T were higher in CHB patients compared to HCs with (P<0.05), also age, W/N, W/H, DBP and ROP were greater in patients with CHB in comparison to HCs, while SBP was greater in HCs than in CHB with (P > 0.05) for these parameters, there was a weak positive correlation between IL-33 with BMI (r=0.254, P= 0.028), other studied variables, did not show significant correlation with IL-33 which gave the following results DBP (r=0.182, P=0.119), W/N(r=0.0170, P=0.885), ROP (r = 0.103, P = 0.379), Age (r = 0.048, P = 0.675), W/T (r = 0.017, P = 0.885) , SBP (r = -0.045, P = 0.704) and W/H (r = -0.081, P = 0.492), respectively. Serum IL-33 levels can be used in the detection of CHB and may be an effective biomarker in the diagnostic test of CHB. | ||
Highlights | ||
| ||
| Keywords | ||
| interleukin-33; CHB; Anthropometric Measurements; BMI | ||
| References | ||
|
[1] Z. Zhu, S. Huang, Y. Zhang, et al, Bioinformatics analysis on multiple Gene Expression Omnibus datasets of the hepatitis B virus infection and its response to the interferon-alpha therapy. BMC infectious diseases, 20(1)(2020), 84-89.
[2] S. Bao, J. Zheng, N. Li, et al, Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage. Clinics and research in hepatology and gastroenterology, 41(2)(2017), 147-155.
[3] S. F.T. Alaaraji, Exploration of the Relationship between Interleukins 17, 37 and 38 with Vitamin E in Iraqi Men with CHB. IOP Conf. Series: Journal of Physics: Conf. Series 1294(2019), 052047.
[4] European Association For The Study Of The Liver, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of hepatology, 67(2)(2017), 370-398.
[5] T. Tu, M. A. Budzinska, N. A. Shackel, et al, HBV DNA integration: molecular mechanisms and clinical implications. Viruses, 9(4)(2017), 75.1-18
[6] R. Bahramabadi, M. S. Fathollahi, S. M. Hashemi, et al, Serum levels of IL-6, IL-8, TNF-α, and TGF-β in chronic HBV-infected patients: effect of depression and anxiety. Laboratory Medicine, 49(1)(2018), 41-46.
[7] T. A. Kolagar, S. R. Mohebbi, F. Ashrafi, et al, Evaluation of IL-17A and IL-17F Gene Expression in Peripheral Blood Mononuclear Cells in Different Clinical Stages of Chronic Hepatitis B Infection in an Iranian Population. Makara Journal of Technology, 24(2)(2020), 59-64.
[8] N. T., Martin, and M. U. Martin, Interleukin 33 is a guardian of barriers and a local alarmin. Nature immunology, 17(2)(2016), 122-131.
[9] S. L. Huan, J. G. Zhao, Wang, Z. L., S. Gao, et al, Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection. BMC infectious diseases,16(1)(2016), 1-8.
[10] K. F. AL-Rawi, H. H. Ali, M. A. Guma, et al, The Relationships of Interleukin-33, Ve-Cadherin and Other Physiological Parameters in Male Patients with Rheumatoid Arthritis. Pertanika Journal of Science & Technology, 30(1)(2022),123-140.
[11] S. F.T. Alaaraji, Serum High-Sensitivity C-Reactive Protein and Endogenous Sex Hormones in Diabetic Men. Journal of Biotechnology Research Center 10 (1)(2016), 48-52.
[12] S. F. Alaaraji, M. M. Awad, and M. A. Ismail, Study the Association of Asprosin and Dickkopf-3 with KIM-1, NTpro-BNP, GDF-15 and CPP among Male Iraqi with Chronic Kidney Disease. Systematic Reviews in Pharmacy, 11(5)(2020), 10-17
[12] K. Neumann, B. Schiller, and G. Tiegs, NLRP3 inflammasome and IL-33: novel players in sterile liver inflammation. International journal of molecular sciences, 19(9)(2018), 2732-2758.
[13] O. Rostan, M. I. Arshad, C. Piquet-Pellorce, et al, Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases. Infection and Immunity, 83(5)(2015), 1738-1748.
[14] R. Weiskirchen, and F. Tacke, Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells. Cellular & molecular immunology, 14(2)(2017), 143-145.
[15] J. Wang, Y. Cai, H. Ji, et al, Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. Journal of Interferon & Cytokine Research, 32(6)(2012), 248-253.
[16] Y. Liang, Z. Jie, L. Hou, et al, IL-33 induces nuocytes and modulates liver injury in viral hepatitis. The Journal of Immunology, 190(11)(2013), 5666-5675.
[17] M. Kolou, G. Katawa, M. Salou, et al, High prevalence of hepatitis B virus infection in the age range of 20-39 years old individuals in Lome. The open virology journal, 11(1)(2017), 1-20.
[18] P. Shah, Y. Iwata, F. Caravaggio, et al, Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis. Schizophrenia research, 208(2019), 420-429.
[19] R. W. H. Hui, W. K. Seto, K. S. Cheung, et al, Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case‐control study. Journal of viral hepatitis, 25(1)(2018), 97-104.
[20] M. Lipowska, T. K. H. Truong, M. Lipowski, et al, The Body as an Object of Stigmatization in Cultures of Guilt and Shame: A Polish–Vietnamese Comparison. International journal of environmental research and public health, 16(16)(2019), 1-17.
[21] R. Fauziana, A. Jeyagurunathan, E. Abdin, et al, Body mass index, waist-hip ratio and risk of chronic medical condition in the elderly population: results from the Well-being of the Singapore Elderly (WiSE) Study. BMC geriatrics, 16(1)(2016), 1-9.
[22] S. D. Painter, I. G. Ovsyannikova, and G. A Poland, The weight of obesity on the human immune response to vaccination. Vaccine, 33(36)(2015), 4422-4429.
[23] N. K. Saxena, and F. A. Anania, Adipocytokines and hepatic fibrosis. Trends in Endocrinology & Metabolism, 26(3)(2015), 153-161.
[24] Y. Li, Y. Zhao, and J. Wu, Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis. PloS one, 12(5)(2017), 1-17.
| ||
|
Statistics Article View: 1,177 PDF Download: 144 |
||